590 related articles for article (PubMed ID: 18440072)
1. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
Cunha-Oliveira T; Rego AC; Oliveira CR
Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072
[TBL] [Abstract][Full Text] [Related]
2. Cocaine addiction as a neurological disorder: implications for treatment.
Majewska MD
NIDA Res Monogr; 1996; 163():1-26. PubMed ID: 8809851
[TBL] [Abstract][Full Text] [Related]
3. [Neuroimaging and drug addiction: neuroanatomical correlates of cocaine, opiates, cannabis and ecstasy abuse].
Verdejo-García A; Pérez-García M; Sánchez-Barrera M; Rodriguez-Fernández A; Gómez-Río M
Rev Neurol; 2007 Apr 1-15; 44(7):432-9. PubMed ID: 17420970
[TBL] [Abstract][Full Text] [Related]
4. Cellular responses to chronic treatment with drugs of abuse.
Nestler EJ
Crit Rev Neurobiol; 1993; 7(1):23-39. PubMed ID: 8385579
[TBL] [Abstract][Full Text] [Related]
5. Opiates, psychostimulants, and adult hippocampal neurogenesis: Insights for addiction and stem cell biology.
Eisch AJ; Harburg GC
Hippocampus; 2006; 16(3):271-86. PubMed ID: 16411230
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse.
Schmitt KC; Reith ME
Ann N Y Acad Sci; 2010 Feb; 1187():316-40. PubMed ID: 20201860
[TBL] [Abstract][Full Text] [Related]
7. Microarray studies of psychostimulant-induced changes in gene expression.
Yuferov V; Nielsen D; Butelman E; Kreek MJ
Addict Biol; 2005 Mar; 10(1):101-18. PubMed ID: 15849024
[TBL] [Abstract][Full Text] [Related]
8. The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders.
Iacovelli L; Fulceri F; De Blasi A; Nicoletti F; Ruggieri S; Fornai F
Exp Neurol; 2006 Sep; 201(1):24-31. PubMed ID: 16678160
[TBL] [Abstract][Full Text] [Related]
9. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis.
Koob GF
Addiction; 2006 Sep; 101 Suppl 1():23-30. PubMed ID: 16930158
[TBL] [Abstract][Full Text] [Related]
10. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
Bubar MJ; Cunningham KA
Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.
Cadet JL; Krasnova IN; Jayanthi S; Lyles J
Neurotox Res; 2007 Apr; 11(3-4):183-202. PubMed ID: 17449459
[TBL] [Abstract][Full Text] [Related]
12. Neurobiologic basis of nicotine addiction and psychostimulant abuse: a role for neurotensin?
Fredrickson P; Boules M; Lin SC; Richelson E
Psychiatr Clin North Am; 2005 Sep; 28(3):737-51, 746. PubMed ID: 16122577
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory neuromodulation of release of amino acid neurotransmitters.
Peris J; Dunwiddie TV
Alcohol Drug Res; 1985-1986; 6(4):253-64. PubMed ID: 2868735
[TBL] [Abstract][Full Text] [Related]
14. Determining the region-specific contributions of 5-HT receptors to the psychostimulant effects of cocaine.
Müller CP; Huston JP
Trends Pharmacol Sci; 2006 Feb; 27(2):105-12. PubMed ID: 16406129
[TBL] [Abstract][Full Text] [Related]
15. Psychostimulants and brain dysfunction: a review of the relevant neurotoxic effects.
Gonçalves J; Baptista S; Silva AP
Neuropharmacology; 2014 Dec; 87():135-49. PubMed ID: 24440369
[TBL] [Abstract][Full Text] [Related]
16. Psychostimulant drugs and a dopamine hypothesis regarding addiction: update on recent research.
Ritz MC; Kuhar MJ
Biochem Soc Symp; 1993; 59():51-64. PubMed ID: 7910741
[TBL] [Abstract][Full Text] [Related]
17. The role of the endogenous cannabinoid system in drug addiction.
Parolaro D; Rubino T
Drug News Perspect; 2008 Apr; 21(3):149-57. PubMed ID: 18560613
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine neurotoxicity: accomplishments and remaining challenges.
McCann UD; Ricaurte GA
Neurosci Biobehav Rev; 2004 Jan; 27(8):821-6. PubMed ID: 15019431
[TBL] [Abstract][Full Text] [Related]
19. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51.
Sharma HS; Sjöquist PO; Ali SF
Curr Pharm Des; 2007; 13(18):1903-23. PubMed ID: 17584116
[TBL] [Abstract][Full Text] [Related]
20. [Neurobiological basis of drug addiction].
Fernández-Espejo E
Rev Neurol; 2002 Apr 1-15; 34(7):659-64. PubMed ID: 12080517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
